News | August 11, 2011

First CREDO Award Given to HHS Office of Minority Health Director Garth Graham

August 11, 2011 — A physician studying the link between behavior and diet and exercise in African-American men is the inaugural recipient of the first award issued by the Coalition to Reduce Disparities in Cardiovascular Disease Outcomes, or CREDO. The coalition is part of the American College of Cardiology (ACC).

Garth Graham, M.D., MPH, FACP, is deputy assistant secretary for minority health and director of the U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH). He was chosen as the first recipient of this award for his tireless dedication and outstanding leadership in eliminating health and healthcare disparities and for the promotion of health equity.

Under Graham’s leadership, HHS recently released two landmark documents: the Action Plan to Reduce Health Disparities and the National Stakeholder Strategy for Achieving Health Equity. The Action Plan outlines goals and actions HHS will take to reduce health disparities among racial and ethnic minorities. The National Stakeholder Strategy details common goals and objectives for public and private sector initiatives and partnerships to help racial and ethnic minorities and other underserved groups reach their full health potential.

“The coalition has decided to honor Dr. Graham with the first CREDO award for his leadership in developing these strategies, and for guiding federal efforts to catalyze a nationwide movement to eradicate health and healthcare disparities,” said Clyde Yancy, M.D., FACC, co-chair of CREDO.

Graham also founded the Boston Men's Cardiovascular Health Project, identifying behavioral explanations for decreased adherence to adequate diet and exercise by African-American men. He has served on the Public Health Executive Council of the Massachusetts Medical Society and the board of directors of Physicians for Human Rights.

CREDO was an initiative started in 2009 based on the need of cardiologists, nurses and other cardiovascular disease clinicians, with the tools and resources to ensure optimal care for their increasingly diverse patients. By developing and disseminating evidence-based educational tools, CREDO seeks to help clinicians better serve all of their patients, regardless of race, ethnicity, gender, primary language or other factors that may impact care.

For more information:

Related Content

Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Overlay Init